Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Martin GR, Beck PL, Sigalet DL.

World J Gastroenterol. 2006 Jul 14;12(26):4117-29. Review.

PMID:
16830359
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Short bowel syndrome: the role of GLP-2 on improving outcome.

Wallis K, Walters JR, Gabe S.

Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):526-32. doi: 10.1097/MCO.0b013e32832d23cd. Review.

PMID:
19474717
[PubMed - indexed for MEDLINE]
3.

Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.

Vegge A, Thymann T, Lund P, Stoll B, Bering SB, Hartmann B, Jelsing J, Qvist N, Burrin DG, Jeppesen PB, Holst JJ, Sangild PT.

Am J Physiol Gastrointest Liver Physiol. 2013 Aug 15;305(4):G277-85. doi: 10.1152/ajpgi.00064.2013. Epub 2013 Jun 13.

PMID:
23764891
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Short bowel syndrome in children: current and potential therapies.

Uko V, Radhakrishnan K, Alkhouri N.

Paediatr Drugs. 2012 Jun 1;14(3):179-88. doi: 10.2165/11594880-000000000-00000. Review.

PMID:
22452596
[PubMed - indexed for MEDLINE]
5.

Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.

Sigalet DL, Bawazir O, Martin GR, Wallace LE, Zaharko G, Miller A, Zubaidi A.

Dig Dis Sci. 2006 Sep;51(9):1557-66. Epub 2006 Aug 22.

PMID:
16927140
[PubMed - indexed for MEDLINE]
6.

Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.

Washizawa N, Gu LH, Gu L, Openo KP, Jones DP, Ziegler TR.

JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):399-409.

PMID:
15568286
[PubMed - indexed for MEDLINE]
7.
8.

Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.

Martin GR, Wallace LE, Sigalet DL.

Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G964-72. Epub 2004 Feb 12.

PMID:
14962847
[PubMed - indexed for MEDLINE]
Free Article
9.

Glucagon-like peptide 2 is a potent growth factor for small intestine and colon.

Litvak DA, Hellmich MR, Evers BM, Banker NA, Townsend CM Jr.

J Gastrointest Surg. 1998 Mar-Apr;2(2):146-50.

PMID:
9834410
[PubMed - indexed for MEDLINE]
10.

Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.

Martin GR, Wallace LE, Hartmann B, Holst JJ, Demchyshyn L, Toney K, Sigalet DL.

Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G431-8. Epub 2004 Sep 23.

PMID:
15388486
[PubMed - indexed for MEDLINE]
Free Article
11.

Glucagon-like Peptide-2.

Estall JL, Drucker DJ.

Annu Rev Nutr. 2006;26:391-411. Review.

PMID:
16602931
[PubMed - indexed for MEDLINE]
12.

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.

Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB.

Gut. 2005 Sep;54(9):1224-31.

PMID:
16099790
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB.

Gastroenterology. 2001 Mar;120(4):806-15.

PMID:
11231933
[PubMed - indexed for MEDLINE]
14.

Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.

Jeppesen PB.

JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):45S-52S. doi: 10.1177/0148607114526241. Epub 2014 Mar 10. Review.

PMID:
24615689
[PubMed - indexed for MEDLINE]
15.

Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.

Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.

Clin Nutr. 2013 Oct;32(5):713-21. doi: 10.1016/j.clnu.2013.03.016. Epub 2013 Mar 28.

PMID:
23587733
[PubMed - indexed for MEDLINE]
16.

Intestinal adaptation following resection.

Tappenden KA.

JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):23S-31S. doi: 10.1177/0148607114525210. Epub 2014 Feb 28. Review.

PMID:
24586019
[PubMed - indexed for MEDLINE]
17.

GLP-2 levels in infants with intestinal dysfunction.

Sigalet DL, Martin G, Meddings J, Hartman B, Holst JJ.

Pediatr Res. 2004 Sep;56(3):371-6. Epub 2004 Jun 16.

PMID:
15201402
[PubMed - indexed for MEDLINE]
18.

Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon.

Haderslev KV, Jeppesen PB, Hartmann B, Thulesen J, Sorensen HA, Graff J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Staun M, Mortensen PB.

Scand J Gastroenterol. 2002 Apr;37(4):392-8.

PMID:
11989828
[PubMed - indexed for MEDLINE]
19.

Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.

Madsen KB, Askov-Hansen C, Naimi RM, Brandt CF, Hartmann B, Holst JJ, Mortensen PB, Jeppesen PB.

Regul Pept. 2013 Jun 10;184:30-9. doi: 10.1016/j.regpep.2013.03.025. Epub 2013 Mar 16.

PMID:
23511332
[PubMed - indexed for MEDLINE]
20.

Intestinal adaptation in short bowel syndrome.

Cisler JJ, Buchman AL.

J Investig Med. 2005 Dec;53(8):402-13. Review.

PMID:
16354579
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk